Social Media Ideas for Biotech Beast

Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence

The deal would add Bio-Techne’s multiomics offerings, analytical technologies, and integrated workflow solutions to German Merck’s platforms and services in research, bioprocessing...

Cogent Biosciences: A Pre-Commercial Biotech With Commercial-Stage Leverage

Absci Corporation: A Big Binary Approaching In Alopecia

Bioprocessing at Full Throttle

Intensified strategies are reshaping biologics manufacturing by boosting speed, flexibility, and productivity without expanding facilities or footprints. The post Bioprocessing at...

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...

Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?

Beam Therapeutics develops precision genetic medicines using base editing technology to target serious inherited diseases.

Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?

Beam Therapeutics develops precision genetic medicines using base editing technology to target serious inherited diseases.

Beigene

Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push

An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.

Bio-Techne, Refeyn Partner on Workflow for Bispecific Antibody, Biosimilar Characterization

The workflow pairs Bio-Techne’s MauriceFlex imaged capillary isoelectric focusing fractionation system with Refeyn's TwoMP mass photometry platform to connect charge heterogeneity...

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

SHENZHEN, China, July 5, 2026 /PRNewswire/ -- MGI's subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, today announced the launch of two...

Legend Biotech

Legend Biotech Anonymous (not verified) Fri, 05/29/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/legend-biotech.701129/...

Kraig Biocraft Labs Creates Immortalized Silk Gland Cell Line

The immortalized cell line developed by Kraig Biocraft Labs’ scientists has also reportedly demonstrated adaptability toward suspension culture systems, which are critical for larg...

From lab to factory floor: ChemT nets US$4M to make cell therapies easier to manufacture

ChemT Biotechnology, a US‑Singapore startup that claims it has built an “intelligence layer” for bio-manufacturing, has raised a total of US$5 million in 18 months, including a US$...

Fueled by M&A and partnerships, biotech is poised for continued growth: EY

Biotech’s effervescent activity has allowed it to overcome headwinds and sustain momentum into 2026, as the volume and value of licensing and M&A deals continues to increase. N...

India's biotech push reaches an inflection point, but funding remains the missing piece

Historically, Indian pharmaceutical companies have focused on generics and services businesses, which carry lower risk and shorter development

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...

A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer

This biotechnology firm leverages machine learning to design novel protein therapeutics targeting unmet medical needs.

Puerto Rico makes its case as a biotech manufacturing hub

Puerto Rico is building on its pharma manufacturing legacy to attract advanced therapy developers seeking scale, regulatory alignment and speed.

Legend Biotech

Legend Biotech Anonymous (not verified) Wed, 05/27/2026 - 11:39 field_thread_url https://cafepharma.com/boards/threads/legend-biotech.701129/...

Biotech Firm Says It Can Cut Gene Therapy Production Time To One Day

A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks or months to manufacture, MedTherapy says it has signi...

Ethyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s Tepezza

Ethyreal Bio has exited stealth with $101 million, joining the queue of companies preparing to challenge Amgen’s Tepezza.

<![CDATA[The Evolving Relationship Between FDA and Biotech]]>

Merck KGaA pledges $50M to build new cardio biotech with eye to later acquisition

Merck KGaA has committed $50 million to build a new biotech with prolific life science investor Versant Ventures, with the ultimate goal of devouring the NewCo down the line.